Find an expert
Our panel of editors are available for interview
Dr James Mountford
Editor-in-Chief of BMJ Leader
Dr James Mountford is Director of Quality at Royal Free London NHS Foundation Trust. He worked initially as an NHS doctor, then in consulting. From 2005-2007, he was a Commonwealth Fund Health Foundation Harkness Fellow based in Massachusetts General Hospital, and at the Institute for Healthcare Improvement (IHI), both in Boston, USA. Before moving to the Royal Free, he was Director of Quality at UCL Partners, an academic health sciences partnership serving a population of 3 million in and around London. He sits on the board of AQuA, the improvement partnership based in north-west England. In March 2020 he was seconded to work as the Chief of Quality and Learning at the NHS Nightingale Hospital London, opened in response to the COVID-19 pandemic.
Professor Gisli Jenkins
Chair of the Editorial Board for BMJ Open Respiratory Research
Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.
Professor Anna Maria Geretti
Editor-in-Chief of Sexually Transmitted Infections
Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases at the Institute of Infection & Global Health of the University of Liverpool, and Honorary Consultant at the Royal Liverpool University Hospital. She trained in Italy, the Netherlands and the UK and has a special interest in HIV, hepatitis B and hepatitis C infection. She has published over 100 peer-reviewed articles, editorials, reviews and book chapters, runs capacity building programmes for resource-limited countries and enthusiastically shares her expertise to train doctors and scientists.
Professor Caroline Finch AO
Editor-in-Chief of Injury Prevention
Professor Caroline Finch AO is the Deputy Vice-Chancellor (Research), Edith Cowan University. She is one of Australia’s leading injury epidemiologists, particularly known internationally for her public-health-focused injury prevention research. Her influential research has informed the development of injury surveillance and data systems, the implementation and evaluation of preventive measures, and the dissemination of safety advice and guidance. Her research outcomes have directly informed safety policy for Government Departments of Sport and Health, health promotion/injury prevention agencies, and sports bodies worldwide. In 2015, she was awarded the International Distinguished Career Award from the American Public Health Association’s Injury Control and Emergency Health Services Section. In 2018, she became an Officer of the Order of Australia for ‘distinguished service to sports medicine’.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
